Reducing The Bioburden Load In Drug Formulation And Filling
By Critical Process Filtration

Controlling bioburden in downstream biopharmaceutical processes is essential for maintaining product quality and protecting critical filtration steps. While sterilizing filters serve as the final safeguard, their effectiveness depends heavily on upstream filtration working efficiently to reduce microbial load. Without proper prefiltration, excess microorganisms — introduced through process streams, materials, or the production environment — can foul sterilizing filters, disrupt batch operations, and increase costs.
A well-designed filtration strategy targets contaminants at multiple stages, removing larger organisms such as molds and yeasts with depth filters, followed by membrane filtration to reduce bacterial levels. Selecting the right filter media and pore size—based on organism size, concentration, and product sensitivity — is key to balancing performance and yield.
Layered bioburden control strengthens filtration performance by reducing fouling, improving reliability, and extending filter life. Gain practical insight into optimizing downstream processes and maintaining consistent product quality in complex manufacturing environments.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.